XTRA:BAYN
XTRA:BAYNPharmaceuticals

Is Bayer (XTRA:BAYN) Resetting Or Repricing After A 1 Year Near-Double In Shares?

If you are trying to work out whether Bayer is genuinely good value or just looks cheap on the surface, you will want a clear view of how the market is currently pricing the stock. The share price sits at €38.95, with returns of 2.4% over the past week, 6.9% over the last month, 2.5% year to date, and 99.6% over the past year, while the 3 year and 5 year returns are 28.2% and 17.2% declines respectively. These mixed results, with a very strong 1 year return against weaker multi year...
XTRA:IFX
XTRA:IFXSemiconductor

Is Infineon’s Silicon Carbide EV Push And Dividend Policy Reframing Its Investment Case (XTRA:IFX)?

Infineon Technologies AG has confirmed an annual dividend of €0.35 per share, payable on February 24, 2026, with the ex-dividend date on February 20 and record date on February 23. Alongside this shareholder payout, Infineon’s push into Silicon Carbide solutions for wireless electric vehicle charging highlights its increasing exposure to emerging power electronics applications. We’ll now explore how Infineon’s expanding Silicon Carbide role in wireless EV charging could influence its...
XTRA:LEG
XTRA:LEGReal Estate

Did Analyst Confidence and Insider Buying Just Reframe LEG Immobilien's (XTRA:LEG) Platform-Model Narrative?

In recent days, analysts have reiterated strong confidence in LEG Immobilien SE, highlighting its transition toward a scaled, platform-style housing operator focused on efficiency, affordability, and ESG-oriented energy upgrades under Germany’s tight regulatory framework. What stands out is the combination of a strong buy analyst consensus and increased insider buying, suggesting that both external analysts and internal stakeholders see the company’s platform model and operational resilience...
XTRA:EVT
XTRA:EVTLife Sciences

Evotec (XTRA:EVT) Is Up 17.3% After Landing €250m Sanofi Alliance And IR Overhaul – Has The Bull Case Changed?

Evotec SE recently entered a five-year multi-component alliance with Sanofi, featuring a minimum guaranteed commitment of €250 million and an upfront payment of more than €40 million, while also appointing Dr. Sarah Fakih as Executive Vice President, Head of Global Communications and Investor Relations to integrate its communications and investor outreach. The combination of a large, multi-year Sanofi commitment across Evotec’s Execute and Innovate segments and a strengthened investor...
XTRA:ENR
XTRA:ENRElectrical

Evaluating Siemens Energy (XTRA:ENR) Valuation As Investor Focus Builds Around Upcoming New York Seminar

Investor attention around Siemens Energy (XTRA:ENR) has picked up as the company prepares to present at the German Investment Seminar in New York on January 12, 2026. CFO and Executive Board member Maria Ferraro will be speaking. See our latest analysis for Siemens Energy. Against this backdrop, Siemens Energy’s €128.20 share price sits after a 1 day share price return of 1.87% and a 90 day share price return of 20.77%. The 1 year total shareholder return of 160.41% and very large 3 year...
XTRA:MRK
XTRA:MRKPharmaceuticals

Why Merck KGaA (XTRA:MRK) Is Up 6.6% After Beating Q4 Profitability Forecasts And What's Next

In the past year, Germany’s Merck KGaA reported that its 2014 group sales rose 3.7%, while fourth-quarter EBITDA excluding one-offs increased 10.5%, both ahead of analyst forecasts. This stronger-than-expected revenue and earnings performance highlighted Merck KGaA’s operational discipline and demand resilience across its core science and technology businesses. We’ll now examine how this earnings beat, particularly the stronger fourth-quarter profitability, could influence Merck KGaA’s...
XTRA:SFQ
XTRA:SFQAuto Components

3 European Dividend Stocks Yielding Up To 5.2%

As European markets continue to show optimism with the STOXX Europe 600 Index rising by 2.27%, investors are increasingly focusing on dividend stocks as a way to capitalize on favorable economic conditions and company earnings. In this environment, selecting stocks that offer consistent dividend yields can be an effective strategy for those looking to generate income while benefiting from the broader market's positive momentum.
XTRA:DHL
XTRA:DHLLogistics

How DHL’s New FDA-Compliant Healthcare Hub At Deutsche Post (XTRA:DHL) Has Changed Its Investment Story

DHL Supply Chain has completed a past investment in a one-million-square-foot, FDA- and GMP-compliant healthcare distribution hub in Annville, Pennsylvania, featuring advanced temperature-controlled and sustainability-focused infrastructure for pharmaceutical, MedTech, and healthcare manufacturers. This facility, aligned with DHL Group’s Strategy 2030 and broader healthcare logistics push, underscores the company’s effort to deepen high-compliance, value-added supply chain services beyond...
XTRA:ADS
XTRA:ADSLuxury

Is adidas (XTRA:ADS) Now Pricing In Too Much Caution After A 31% One-Year Slide

If you are wondering whether adidas at €166.65 is a bargain or still priced for perfection, you are in the right place for a clear look at what the current share price really implies. The stock has seen a 0.4% decline over the last week, a 0.5% decline over the last month, a 0.4% decline year to date, and a 31.0% decline over the last year. The 3 year return sits at 15.6%, and the 5 year return at a 38.1% decline. Recent discussion around adidas has centered on how the brand is positioned in...
XTRA:MTX
XTRA:MTXAerospace & Defense

Should MTU Aero Engines’ Zero‑Coupon 2033 Convertible Refinancing Reshape Dilution Risks for (XTRA:MTX) Investors?

Earlier this week, MTU Aero Engines AG issued new senior unsecured convertible bonds with a principal amount of €600 million, maturing in July 2033, bearing no interest, a 47.5% conversion premium and an accreted redemption price of 105%, to refinance its 2027 convertible bonds and support general corporate purposes. By using the new zero‑coupon 2033 convertible bonds to repurchase up to €500 million of 2027 bonds, MTU is reshaping its capital structure, extending debt maturities and...
XTRA:TMV
XTRA:TMVSoftware

How Investors Are Reacting To TeamViewer (XTRA:TMV) Rising Insider Buying And Renewed Analyst Optimism

In recent days, Barclays’ Alice Jennings and Kepler Capital have reiterated positive analyst views on TeamViewer SE, while corporate insiders have increased their share purchases, signalling stronger internal confidence in the company’s prospects. At the same time, a voting rights notification from Norway’s Ministry of Finance highlights shifting institutional ownership, adding an extra layer of context to this upswing in insider optimism. Now we’ll explore how this upswing in insider share...